Subacute Thyroiditis: Triggers, Symptoms, and the 3 Phases

Subacute thyroiditis is a self-limiting inflammatory condition of the thyroid gland that typically causes neck pain, fever, and temporary disruption of thyroid hormone levels. First described by the Swiss surgeon Fritz de Quervain in 1904, it remains one of the more common causes of a painful thyroid, and it follows a distinctive pattern that sets it apart from other thyroid disorders. Though the condition usually resolves on its own within a few months, the experience can be surprisingly miserable, and the path from onset to recovery is more complicated than many people expect.

What Triggers It

For decades, the standard explanation has been that subacute thyroiditis is triggered by a viral infection, often an upper respiratory illness that precedes the thyroid symptoms by a few weeks. Case reports have linked it to a range of viruses including coxsackievirus, mumps, measles, and adenovirus.1American Journal of Case Reports. Subacute Thyroiditis: An Unusual Presentation of Fever of Unknown Origin Following Upper Respiratory Tract Infection Viral infections have long been cited as a major environmental factor in triggering the condition.2PubMed Central. Viruses and thyroiditis: an update

That said, the viral theory is not as airtight as textbooks sometimes suggest. A recent study analyzing whether specific viruses actually correlate with subacute thyroiditis cases found strong evidence that enteroviruses like echovirus and coxsackievirus, despite having a seasonal pattern that overlaps with the disease, are not the direct cause. The same study found no association with influenza, parainfluenza, rhinovirus, or coronaviruses including SARS-CoV-2.3PubMed Central. Subacute Thyroiditis-Is it Really Linked to Viral Infection? The condition may instead reflect a post-viral inflammatory reaction rather than a direct viral assault on the thyroid. In other words, the virus might be long gone by the time the thyroid starts acting up. The immune system’s overreaction, not the virus itself, may be the real culprit.

A Genetic Component

Not everyone who catches a cold gets subacute thyroiditis, and that has led researchers to look at genetics. A strong link exists between the condition and a specific immune marker called HLA-B35. Studies across multiple ethnic groups have confirmed this association, and research on identical twins who both developed subacute thyroiditis years apart strengthened the case for a genetic role.4PubMed. Susceptibility to subacute thyroiditis is genetically influenced: familial occurrence in identical twins

A Dutch family study illustrated the point vividly. Several family members developed subacute thyroiditis at different times spanning from 1986 to 2002, despite living more than 50 miles apart. All of them carried the HLA-B35 marker.5PubMed. Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35 The fact that they got sick in different regions and in different years makes a shared environmental exposure unlikely, which points to their shared genetics as the key risk factor. The current working model is that subacute thyroiditis probably requires both a triggering event (possibly viral, possibly something else) and a genetic predisposition to develop the exaggerated inflammatory response in the thyroid.

The Three-Phase Course

One of the hallmarks of subacute thyroiditis is its triphasic pattern, and understanding this pattern is essential for anyone going through it, because each phase feels different and requires different management.

In the first phase, inflammation damages thyroid cells and causes them to dump their stored hormones into the bloodstream. This creates a period of excess thyroid hormone that typically lasts one to three months. During this stage you might experience a rapid heartbeat, anxiety, tremor, heat intolerance, and weight loss, alongside the hallmark neck pain and tenderness. The thyroid is not actually overproducing hormone; it is leaking it. That distinction matters for treatment, as we will see.

The second phase is a hypothyroid period that can last up to six months. The thyroid’s hormone stores have been depleted by the first phase, and the gland is too damaged to produce enough hormone on its own yet. Fatigue, weight gain, feeling cold, and sluggish thinking are common complaints.

The third phase is recovery, when the thyroid gradually rebuilds and returns to normal function.6PubMed. Subacute, silent, and postpartum thyroiditis Not every patient experiences all three phases distinctly. Some people skip the hypothyroid phase entirely, while others never notice much in the way of overactive thyroid symptoms. The textbook progression is the classic arc, but individual experiences vary widely.

What the Symptoms Actually Feel Like

The symptom that brings most people to the doctor is pain. The front of the neck becomes tender, often on one side initially before spreading to the other. The pain can radiate to the jaw or ear, which sometimes leads to misdiagnosis as a dental problem or ear infection. Many people also develop a low-grade fever, fatigue, and general malaise that feels like a lingering flu.

The thyroid gland itself often feels firm and enlarged on examination. During the first phase, symptoms of excess thyroid hormone (palpitations, jitteriness, sweating) may be prominent. Some people, though, present with atypical features that make diagnosis trickier. One documented case involved a 40-year-old woman whose subacute thyroiditis presented as painful thyroid nodules without any biochemical evidence of excess thyroid hormone.7PubMed Central. Subacute thyroiditis presenting as a painful suspicious thyroid nodule These atypical presentations, which can include a normal inflammatory marker level or the absence of pain, mean that a normal-looking set of blood tests does not automatically rule out subacute thyroiditis.

How It Is Diagnosed

Diagnosis relies on a combination of clinical findings, blood work, and imaging. No single test is definitive on its own, so doctors typically piece together several clues.

Blood Tests

During the initial phase, blood tests usually show low TSH (the pituitary signal that tells the thyroid to work) and elevated levels of thyroid hormones T4 and T3, along with elevated thyroglobulin, a protein released when thyroid cells are damaged.8PubMed Central. Acute and Subacute, and Riedel’s Thyroiditis Inflammatory markers are typically elevated. The erythrocyte sedimentation rate (ESR), a general marker of inflammation, is often quite high. C-reactive protein (CRP), another inflammation marker, tends to rise as well. Research comparing the two suggests CRP may be the better gauge of how severe the inflammation is and whether steroid treatment will be needed. In one study, a CRP level above roughly 19 mg/L was a more specific predictor of needing glucocorticoid therapy than ESR, which, while very sensitive, flagged many patients who ultimately did not need steroids.9PubMed Central. C-Reactive Protein Level can be a Better Indicator than Erythrocyte Sedimentation Rate in Assessing the Severity of Inflammation and Guiding Glucocorticoid Therapy in Subacute Thyroiditis

Imaging

Radioactive iodine uptake testing can be particularly useful in distinguishing subacute thyroiditis from Graves’ disease, the other common cause of elevated thyroid hormones. In Graves’ disease, the thyroid is actively overproducing hormone and eagerly sucks up iodine. In subacute thyroiditis, the gland is damaged and leaking, so uptake is very low. One study found the average uptake in subacute thyroiditis patients to be around 3%, which was significantly different from all other thyroid conditions tested.10Journal of Nuclear Medicine Technology. Patterns of Thyroid Radioiodine Uptake: Jordanian Experience

Ultrasound provides another diagnostic window. The classic ultrasound appearance shows ill-defined areas of low echogenicity (dark patches) in the thyroid, and these areas do not show increased blood flow.11PubMed Central. Ultrasonographic characteristics of subacute granulomatous thyroiditis That lack of increased blood flow is another way to distinguish subacute thyroiditis from Graves’ disease, where the thyroid is typically swimming in blood supply. Ultrasound is widely available, painless, and avoids radiation, making it a practical first-line imaging choice.

Fine-Needle Aspiration

In cases where the diagnosis is unclear or a nodule looks suspicious on ultrasound, a fine-needle aspiration biopsy can help. The classic findings under the microscope include damaged follicular cells, a messy background of inflammatory debris, and the presence of multinucleated giant cells, which were found in 19 out of 20 cases in one cytological review.12PubMed Central. Fine-Needle Aspiration of De Quervain’s Thyroiditis (Subacute Granulomatous Thyroiditis): A Cytological Review of 20 Cases These giant cells are a hallmark of the granulomatous inflammation that gives the condition its other name, granulomatous thyroiditis.

Treatment

Because subacute thyroiditis is self-limiting, treatment focuses on controlling symptoms rather than curing the underlying disease. The two mainstays are anti-inflammatory medications and, when symptoms are severe, corticosteroids.

For mild to moderate cases, nonsteroidal anti-inflammatory drugs like ibuprofen or naproxen are the first choice. They address the pain and inflammation directly and work well for many patients.13PubMed Central. Management of Subacute Thyroiditis – A Systematic Review of Current Treatment Protocols When NSAIDs are not enough, oral corticosteroids such as prednisone are typically the next step. Steroids bring faster relief from pain and inflammation, but they come with the usual side effects of steroid therapy (weight gain, mood changes, elevated blood sugar, sleep disruption), especially with longer courses. The standard approach is a tapering course over several weeks.14PubMed Central. Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis

For the small number of patients whose disease keeps flaring despite oral steroids, high-dose intravenous methylprednisolone has shown promise. In patients with relapsing subacute thyroiditis unresponsive to oral steroids, intravenous pulse therapy led to rapid improvement in both symptoms and ultrasound findings, with shorter overall treatment duration and few side effects.15PubMed Central. High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids

During the thyrotoxic first phase, beta-blockers can help tame the racing heart, tremor, and anxiety. These drugs do not treat the thyroid problem itself but block the effect of excess thyroid hormone on the heart and nervous system.16The American Journal of Medicine. Review β-Adrenergic blockade for the treatment of hyperthyroidism Anti-thyroid drugs like methimazole, which are standard for Graves’ disease, are not used here because the thyroid is not overproducing hormone. It is simply leaking stored hormone from damaged cells, and blocking production would have no useful effect.

Distinguishing Subacute from Suppurative Thyroiditis

A condition that can initially mimic subacute thyroiditis is acute suppurative thyroiditis, a rare but potentially dangerous bacterial infection of the thyroid gland. Both conditions cause neck pain, tenderness, fever, and elevated inflammatory markers. The overlap in symptoms can make the two hard to tell apart early on.17PubMed. Suppurative thyroiditis: Systematic review and clinical guidance The key differences are that suppurative thyroiditis tends to progress more rapidly, may produce pus visible on ultrasound or aspiration, and requires antibiotics or surgical drainage rather than anti-inflammatory therapy. Anyone with worsening neck swelling, very high fevers, or symptoms that do not respond to standard subacute thyroiditis treatment should be evaluated for this alternative diagnosis.

The COVID-19 Connection

The COVID-19 pandemic brought subacute thyroiditis into renewed focus. SARS-CoV-2 infection itself was reported as a trigger for the condition, consistent with the broader theory of post-viral thyroid inflammation.18PubMed Central. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence More unexpectedly, COVID-19 vaccines were also associated with cases of subacute thyroiditis. Case reports emerged following mRNA vaccinations in particular.19PubMed Central. Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19

To put this in perspective, the absolute number of post-vaccination cases remains small relative to the hundreds of millions of doses administered, and the cases that did occur followed the typical self-limiting course. The reports are important for clinical awareness, especially in someone who develops neck pain and thyroid dysfunction in the weeks after vaccination, but they do not change the overall risk-benefit calculation of vaccination. These cases do add to the broader picture of subacute thyroiditis as an immune-mediated response that can be set off by various immune stimuli, not just classical viral infections.

Long-Term Outlook and Recurrence

The traditional reassurance about subacute thyroiditis has been that nearly everyone makes a full recovery. For most people, that holds true. A small long-term follow-up study averaging about eight years found that the vast majority of patients had recovered normal thyroid function, whether spontaneously or after temporary thyroid hormone supplementation during the hypothyroid phase.20PubMed Central. Subacute Thyroiditis: Clinical Presentation and Long Term Outcome

However, the risk of permanent hypothyroidism is higher than traditionally thought. One study found that more than a quarter of patients developed permanent hypothyroidism within three years of their episode.21PubMed. Long-term Outcome of Subacute Thyroiditis That is a substantially larger fraction than the “rare” label that older sources often apply to this outcome. The discrepancy likely reflects differences in follow-up length and how rigorously thyroid function was monitored after the acute episode resolved. The practical takeaway is that anyone who has had subacute thyroiditis should have their thyroid levels checked periodically for several years afterward, not just once at the three-month mark.

Recurrence is another concern. A meta-analysis of 18 cohort studies found a pooled recurrence rate of about 12%.22PubMed Central. Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies Roughly one in eight patients goes through the whole ordeal again at some point. Recurrences can happen months or years after the initial episode and typically follow the same pattern. For those who carry the HLA-B35 marker or who had a particularly severe initial episode, the risk may be higher, though precise predictors are still being refined.

Subacute Thyroiditis During Pregnancy

Subacute thyroiditis is rarely diagnosed during pregnancy, with only a handful of cases documented in the medical literature.23PubMed Central. Subacute thyroiditis during early pregnancy: a case report and literature review The rarity may partly reflect genuine infrequency and partly reflect diagnostic difficulty, since pregnancy itself can alter thyroid function and mask or mimic the hormonal changes caused by thyroiditis.

When it does occur, the concern is less about the thyroiditis itself and more about the thyroid dysfunction it causes. Excess thyroid hormone during the first trimester can increase the risk of complications for both the pregnant person and the fetus. Treatment options are somewhat constrained: NSAIDs are generally avoided in the third trimester, and corticosteroid use requires careful weighing of benefits against potential effects on the pregnancy. Beta-blockers can be used cautiously for symptomatic relief of a racing heart. Diagnosing the condition early is considered particularly important in pregnancy so that thyroid hormone levels can be monitored closely and managed appropriately.24PubMed Central. Subacute thyroiditis in pregnancy: a narrative review

Why the Viral Theory Persists Despite Thin Evidence

It is worth dwelling on a tension in the field. The viral trigger hypothesis for subacute thyroiditis has been accepted for so long that it appears in virtually every endocrinology textbook as established fact. Yet the strongest direct test of this idea, looking for actual viral correlations, came up empty. The study that systematically analyzed whether enteroviruses, influenza, parainfluenza, rhinoviruses, or coronaviruses were associated with subacute thyroiditis cases found no link for any of them.25PubMed Central. Subacute Thyroiditis-Is it Really Linked to Viral Infection?

So why does the viral theory persist? Part of the answer is that many patients do recall a respiratory illness before onset, and the seasonal peaks in subacute thyroiditis do roughly track with common viral seasons. But correlation at the population level does not prove causation, especially when direct testing finds no association. Another part of the answer is the post-vaccination cases, which show that immune activation of various kinds, not just viral infection, can trigger the condition. The emerging picture may be that subacute thyroiditis is better understood as a disorder of immune dysregulation in genetically susceptible individuals, with viral infection being one of many possible triggers rather than a necessary cause. The HLA-B35 link supports this reframing: the immune system’s wiring matters at least as much as what sets it off.

This shift in understanding also has practical implications. If subacute thyroiditis is not tightly linked to any one virus, there is no particular infection to avoid or vaccine to hope for. Instead, the susceptibility is baked into a person’s immune genetics, and virtually any sufficiently provocative immune stimulus might set things in motion. For people who have had one episode and carry the genetic marker, the recurrence rate of about 12% reflects that ongoing vulnerability.